Moderate EvidenceAntioxidant / Mitochondrial Nutrient2 products compared

Alpha-Lipoic Acid for PCOS: Evidence for the Inflammatory Phenotype

Not all PCOS presents with the same pathophysiology. For women whose PCOS is characterized by elevated inflammatory markers — raised CRP, oxidative stress biomarkers, or HMGB1 (a damage-associated molecular pattern protein) — the inflammatory cascade is a co-driver of insulin resistance and androgen excess, not just a downstream consequence. The Inflammatory PCOS phenotype responds to interventions that address oxidative stress and inflammation alongside insulin signaling. Alpha-lipoic acid (ALA) occupies a distinctive position in the PCOS supplement landscape because it operates at this intersection: it is both an insulin sensitizer and a potent antioxidant/anti-inflammatory agent. Where inositol works upstream at the insulin second-messenger level, and berberine targets AMPK and the liver, ALA targets the oxidative and inflammatory mechanisms at the mitochondrial level — making it mechanistically complementary rather than redundant. The clinical evidence in PCOS is specifically developed. Guarano et al. (2023, PMID 37513627) reviewed ALA efficacy in PCOS treatment in a dedicated analysis. Multiple clinical studies have examined ALA specifically combined with myo-inositol in PCOS, including Fruzzetti et al. (2020, PMID 31317814) on long-term effects on clinical and metabolic features, De Cicco et al. (2017, PMID 28434274) on ALA's mechanism in PCOS, and Cirillo et al. (2020, PMID 32054355) on ALA's specific effect on HMGB1 in adolescent PCOS — connecting the anti-inflammatory mechanism to the Inflammatory PCOS phenotype. The R-form of ALA (R-ALA) is the biologically active enantiomer and the preferred form for mitochondrial antioxidant effects. This page explains why form matters and ranks two products accordingly. Research suggests ALA may support PCOS symptom management — it is not a treatment for PCOS itself.

Written by Editorial Team·Medically reviewed by Angelique Nicole R. Villegas, RND, Registered Nutritionist Dietitian · PRC Philippines · License #0023950·Updated June 13, 2026·How we picked these products

This content is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement.

Why It Works

Key Benefits of Alpha-Lipoic Acid for PCOS

Research suggests ALA may support clinical and metabolic features of PCOS over a 3–6 month course — based on Fruzzetti et al. 2020 (PMID 31317814) studying long-term ALA + myo-inositol in PCOS

May reduce HMGB1, a key inflammatory and oxidative stress marker elevated in PCOS — directly relevant to the Inflammatory PCOS phenotype, based on Cirillo et al. 2020 (PMID 32054355)

ALA may contribute to PCOS improvement via an insulin-independent antioxidant mechanism — distinct from inositol's insulin second-messenger pathway, making the combination mechanistically additive (De Cicco 2017, PMID 28434274)

Our Picks

Best Alpha-Lipoic Acid for PCOS in 2026

Ranked by quality, value, and clinical backing

Where available, we show when each product price was last checked so the list stays honest without overreacting to normal Amazon price movement.

🏆Best Overall

#1Editor's Choice

8.8

Doctor's Best

Doctor's Best R-Lipoic Acid (BioEnhanced Na-RALA)

4.6

$26.99/ $0.45 per serving

The R-form precision pick. Pure R-lipoic acid as stabilized sodium salt — the biologically active enantiomer with superior mitochondrial targeting. Preferred for the Inflammatory PCOS phenotype where antioxidant mechanism is the priority.

Women with Inflammatory PCOS phenotype who prioritize the biologically active R-form and oxidative stress mechanism, and are willing to take multiple capsules for the purest form

Pros

Pure R-form: the endogenously produced enantiomer that acts as a mitochondrial enzyme cofactor — no inert S-ALA competing for uptake

BioEnhanced sodium R-lipoate (GeroNova): stabilized salt form that prevents the rapid degradation affecting standard racemic ALA

Dose flexibility: 100mg per capsule allows precise titration from 200mg to 600mg R-ALA daily

Strong review base (8,700+) with consistent quality feedback

Cons

Requires 3–6 capsules to reach 300–600mg R-ALA daily (equivalent to 600mg–1200mg racemic ALA doses)
Higher per-unit cost (~$0.45/capsule vs ~$0.15 for NOW 600mg racemic)
GMP but not NSF certified

GMP CertifiedNon-GMO VerifiedVeganGmp CertifiedNon Gmo Verified

Trust Context

Third-party testing signal notedNo active FDA recall foundNo tainted-supplement match found

Evidence

Limited evidencescore 10composite 35.4

Buy Doctor's Best R-Lipoic Acid (BioEnhanced Na-RALA)$26.99

#2 Runner-Up

8.2

NOW Foods

NOW Foods Alpha Lipoic Acid 600mg

4.5

$17.99/ $0.15 per serving

The dose-matched value pick. 600mg racemic ALA per capsule matches the doses used in published PCOS clinical studies, at the lowest per-serving cost available.

Cost-conscious women with PCOS who want the dose used in published PCOS clinical studies in a single capsule, and are comfortable with racemic form

Pros

600mg per capsule matches higher-dose PCOS clinical trial doses (Fruzzetti 2020 and related studies used 400–600mg ALA)

Best per-serving value in ALA category (~$0.15/day for 600mg)

NOW GMP certification, large review base (11,200+ reviews)

Single-capsule convenience at the studied dose

Cons

Racemic blend: delivers 300mg R-ALA + 300mg biologically inactive S-ALA per capsule
Standard racemic ALA is less stable than sodium R-lipoate form — store away from heat and humidity
No NSF certification

GMP CertifiedNon-GMO VerifiedVeganKosherGmp CertifiedNon Gmo Verified

Trust Context

Third-party testing signal notedNo active FDA recall foundNo tainted-supplement match found

Evidence

Limited evidencescore 10composite 128.2

Buy NOW Foods Alpha Lipoic Acid 600mg$17.99

Free Buyer Guide

Compare supplements with the same checklist we use.

Get the anti-aging supplement cheat sheet with evidence prompts, safety checks, and label-quality questions before you buy.

Get the guide

Side-by-Side

Comparison Table

Category	#1 Doctor's Best R-Lipoic Acid (BioEnhanced Na-RALA) Doctor's Best	#2 NOW Foods Alpha Lipoic Acid 600mg NOW Foods
Score	8.8/10	8.2/10
Best For	Women with Inflammatory PCOS phenotype who prioritize the biologically active R-form and oxidative stress mechanism, and are willing to take multiple capsules for the purest form	Cost-conscious women with PCOS who want the dose used in published PCOS clinical studies in a single capsule, and are comfortable with racemic form
Pros	Pure R-form: the endogenously produced enantiomer that acts as a mitochondrial enzyme cofactor — no inert S-ALA competing for uptake BioEnhanced sodium R-lipoate (GeroNova): stabilized salt form that prevents the rapid degradation affecting standard racemic ALA	600mg per capsule matches higher-dose PCOS clinical trial doses (Fruzzetti 2020 and related studies used 400–600mg ALA) Best per-serving value in ALA category (~$0.15/day for 600mg)
Cons	Requires 3–6 capsules to reach 300–600mg R-ALA daily (equivalent to 600mg–1200mg racemic ALA doses)	Racemic blend: delivers 300mg R-ALA + 300mg biologically inactive S-ALA per capsule

The Science

How Alpha-Lipoic Acid Supports PCOS

Alpha-lipoic acid operates through two mechanistically distinct pathways relevant to PCOS pathophysiology. The insulin-sensitizing pathway: ALA activates AMPK (AMP-activated protein kinase) in skeletal muscle and liver, improving glucose uptake independent of insulin receptor activation. ALA also enhances mitochondrial function and glucose oxidation — relevant because PCOS-associated mitochondrial dysfunction impairs energy metabolism in ovarian cells and skeletal muscle. The Genazzani 2019 study (PMID 31304823) documented differential insulin responses in PCOS women taking ALA versus myo-inositol, suggesting the two agents address complementary steps in insulin signaling. The antioxidant / anti-inflammatory pathway: ALA is a cofactor for mitochondrial dehydrogenases and functions as a potent antioxidant in both lipid and aqueous cellular compartments — an unusual dual-phase antioxidant capability. ALA regenerates other antioxidants including glutathione, vitamin C, and vitamin E. In the PCOS context, oxidative stress drives insulin resistance, impairs oocyte quality, and contributes to androgen production in thecal cells. ALA's antioxidant mechanism directly addresses this inflammatory amplification loop. The Cirillo 2020 HMGB1 data (PMID 32054355) is the most specific evidence connecting ALA's antioxidant action to PCOS inflammatory markers. The R-form specificity: only the R-enantiomer of lipoic acid is produced endogenously and acts as a cofactor in mitochondrial enzyme complexes. S-ALA (the synthetic byproduct) does not serve as a mitochondrial cofactor and may compete with R-ALA for cellular uptake at high doses. For the anti-inflammatory mitochondrial mechanism specifically, R-ALA is mechanistically superior. Commercial racemic ALA (like NOW 600mg) still delivers meaningful R-ALA — 600mg racemic = 300mg R-ALA — but at the cost of 300mg inert S-ALA per dose.

Buying Guide

What to Look For When Buying Alpha-Lipoic Acid

The first decision in ALA shopping for PCOS is form: R-ALA (pure active enantiomer) versus racemic ALA (50% R, 50% inactive S). For the Inflammatory PCOS phenotype — where you are targeting mitochondrial antioxidant mechanisms specifically — R-form has the stronger mechanistic rationale. However, the PCOS clinical trials (Fruzzetti 2020, De Cicco 2017, Genazzani 2019, Cirillo 2020) all used standard racemic ALA in the 400–600mg dose range. If your primary criterion is matching the clinical trial evidence, NOW 600mg racemic is the most direct match. If your primary criterion is the purest mitochondrial-active antioxidant form, Doctor's Best R-Lipoic Acid at 200–300mg R-ALA (2–3 capsules) delivers more biologically active ALA per milligram. The combination question: most PCOS ALA evidence exists in the context of ALA combined with myo-inositol, not ALA alone. De Cicco (2017) specifically established that ALA's contribution is insulin-independent — meaning combining ALA with inositol covers two distinct mechanisms. If you are already taking inositol (highly recommended as the primary PCOS intervention), adding ALA at 400–600mg daily is a coherent step, particularly if inflammatory markers or oxidative stress features are present in your presentation. If you have not tried inositol, start there first. Dosing context from PCOS studies: most published PCOS protocols have used ALA in the 400–600mg daily range (racemic) divided into two doses with meals. Fruzzetti 2020 used the combination approach. If using Doctor's Best R-ALA, 200mg R-ALA twice daily (4 capsules) is approximately dose-equivalent in biologically active ALA to 600–800mg racemic ALA. ALA and blood sugar: ALA has meaningful insulin-sensitizing and glucose-lowering effects. If you take insulin, metformin, or any glucose-lowering medication, add ALA with clinician awareness and monitor blood glucose. This is especially important at the higher doses used in PCOS protocols. For adolescent PCOS specifically: the Cirillo 2020 study (PMID 32054355) studied ALA + myo-inositol in adolescents with PCOS and documented HMGB1 reduction — the most direct inflammatory mechanism evidence. If PCOS was diagnosed in adolescence and inflammatory features are prominent, this combination has the most direct evidence base. Expect 3–6 months before assessing hormonal and cycle endpoint change. ALA's antioxidant effects may reduce fatigue and skin oxidative symptoms within 4–8 weeks; cycle-length normalization and hormonal marker improvement require longer observation.

Dosage

Dosage Guidance

The PCOS clinical literature has predominantly used ALA in the 400–600mg daily range as racemic ALA, often split into two doses taken with meals. The combination with myo-inositol is the most studied protocol — typically 600mg racemic ALA + 2,000mg myo-inositol daily, with or without D-chiro-inositol. For Doctor's Best R-Lipoic Acid: 2 capsules (200mg R-ALA) twice daily with meals = 400mg R-ALA daily, approximately equivalent in biological activity to 600–800mg racemic ALA. Some practitioners use 3 capsules twice daily (600mg R-ALA) for more significant inflammatory presentations. For NOW Foods ALA 600mg: 1 capsule daily with a meal is the starting dose. Some PCOS protocols use 2 capsules (1,200mg racemic ALA = 600mg R-ALA equivalent) but this exceeds the typical range studied in PCOS trials and should be discussed with a clinician. Take ALA with meals — it is fat-soluble and absorption is enhanced by food. Avoid taking ALA at the same time as iron supplements: ALA chelates iron and may reduce iron absorption when taken simultaneously (space by 2 hours). Critical safety note: ALA has meaningful glucose-lowering effects. If you take insulin, metformin, or other glucose-lowering medications, monitor blood glucose and discuss ALA addition with your prescriber before starting. Do not self-escalate above 600mg daily without clinical guidance. Consult your healthcare provider before starting ALA if you are pregnant, have thiamine deficiency (ALA can worsen symptoms), are taking thyroid medications, or have a history of hypoglycemia.

Always follow your healthcare provider's recommendations. Dosages vary by individual health status, age, and goals.

What Users Complain About

Common Alpha-Lipoic Acid Complaints (And How to Avoid Them)

Based on analysis of thousands of customer reviews across Alpha-Lipoic Acid products.

"ALA upsets my stomach — should I stop?"

GI upset (nausea, heartburn) is the most common side effect of ALA supplementation, particularly with higher doses of racemic ALA on an empty stomach. Take ALA with a full meal, not fasted. If using NOW 600mg, splitting into two 300mg doses (half a capsule, which is difficult) or switching to Doctor's Best R-ALA at 100mg increments may help. Starting at 200–300mg daily and building up over 2–3 weeks also reduces initial GI sensitivity. If upset persists beyond 2 weeks at low doses, discuss with your clinician.

"I thought ALA was for diabetic neuropathy — why is it on a PCOS page?"

ALA has the strongest evidence base (and is approved in Germany) for diabetic neuropathy — so you're right that this is its best-established clinical use. However, ALA's insulin-sensitizing and antioxidant mechanisms are relevant beyond neuropathy. In PCOS, the same pathways — AMPK activation, mitochondrial antioxidant activity, insulin signaling improvement — are active in a different target population. The PCOS-specific clinical literature (Guarano 2023, Fruzzetti 2020, De Cicco 2017, Cirillo 2020) validates this application specifically, and the mechanism is coherent. The dose range used in PCOS (400–600mg racemic ALA) is also within the range studied for neuropathy.

"My doctor says there isn't enough evidence for ALA in PCOS — is this page overstating it?"

Your doctor's caution is appropriate calibration. The ALA-PCOS evidence base is real but carries important limitations: most studies use ALA in combination with myo-inositol (making ALA's independent contribution hard to isolate), sample sizes are modest, and the evidence hasn't yet reached guideline-level (the 2023 PCOS guidelines don't specifically recommend ALA). We acknowledge these limitations directly in the evidence snapshot section. Our positioning is 'well-supported adjunct, particularly for Inflammatory phenotype' — not a first-line or standalone treatment. That framing is consistent with the current evidence weight.

Safety

Safety & Interactions

**PCOS and ongoing medical care:** PCOS is a medical diagnosis requiring clinician follow-up. Supplements are adjuncts to — not replacements for — evaluation by an endocrinologist, gynecologist, or primary care physician. If you take metformin, oral contraceptives, spironolactone, or fertility medications, discuss any supplement addition with your prescriber. **Hypoglycemia risk with insulin-lowering medications:** ALA has meaningful insulin-sensitizing and glucose-lowering effects. Women on insulin, metformin, sulfonylureas, or other hypoglycemic agents should monitor blood glucose and inform their prescriber before adding ALA. A hypoglycemic episode is possible if both ALA and medication produce additive effects. **Thiamine (Vitamin B1) status:** There are isolated case reports of ALA supplementation precipitating thiamine deficiency symptoms in individuals with marginal thiamine status. This is particularly relevant for women with restrictive dietary patterns, alcoholism, or conditions affecting B1 absorption. Ensure adequate dietary thiamine or supplementation if using ALA long-term. **Iron chelation:** ALA chelates iron and may reduce iron absorption when taken simultaneously with iron supplements. Space ALA and iron supplementation by at least 2 hours. Women with iron-deficiency anemia should inform their clinician before starting ALA. **Thyroid medication interaction:** ALA may affect thyroid hormone uptake; women on levothyroxine or other thyroid medications should space ALA supplementation from thyroid medication by at least 4 hours. **Pregnancy and breastfeeding:** Consult your healthcare provider before taking this supplement during pregnancy or while nursing. The safety of supplemental doses beyond dietary intake has not been established in pregnant or lactating women. **Blood thinners:** If you take blood-thinning medications (e.g., warfarin, apixaban, rivaroxaban, clopidogrel, or high-dose aspirin), consult your healthcare provider BEFORE starting this supplement, as it may have additive antiplatelet or anticoagulant effects. **Kidney disease:** If you have chronic kidney disease (CKD) or any significant kidney impairment, consult your healthcare provider before taking this supplement. Some supplements can accumulate to dangerous levels when kidney function is reduced. **Gout:** Individuals with gout should consult their healthcare provider before starting this supplement. Certain supplements (e.g., collagen, fish oil, niacin) may affect uric acid levels or trigger flares in susceptible individuals.

Standard safety disclaimers

Pregnancy and breastfeeding: Consult your healthcare provider before taking this supplement during pregnancy or while nursing. The safety of supplemental doses beyond dietary intake has not been established in pregnant or lactating women.
Blood thinners: If you take blood-thinning medications (e.g., warfarin, apixaban, rivaroxaban, clopidogrel, or high-dose aspirin), consult your healthcare provider BEFORE starting this supplement, as it may have additive antiplatelet or anticoagulant effects.
Kidney disease: If you have chronic kidney disease (CKD) or any significant kidney impairment, consult your healthcare provider before taking this supplement. Some supplements can accumulate to dangerous levels when kidney function is reduced.
Gout: Individuals with gout should consult their healthcare provider before starting this supplement. Certain supplements (e.g., collagen, fish oil, niacin) may affect uric acid levels or trigger flares in susceptible individuals.
Important: This supplement is not a replacement for prescription medications. It is supportive for individuals with low baseline status, not a treatment for diagnosed conditions (anxiety disorders, insomnia, hypertension, osteoporosis, etc.). Do not stop or reduce any prescription without consulting your doctor.

"
"ALA's position in the Inflammatory PCOS phenotype is mechanistically well-reasoned: it sits at the intersection of antioxidant support (glutathione regeneration, HMGB1 reduction) and insulin sensitization (AMPK activation, mitochondrial function), which is exactly where oxidative-stress-driven PCOS pathophysiology operates. In practice, I would position it as the second-line addition after inositol in inflammatory-pattern PCOS — not as a replacement. The R-form makes the most mechanistic sense for the antioxidant pathway specifically, but the racemic form at 400–600mg is the dose range validated in PCOS clinical studies. Whichever form you choose, take it with meals and be mindful of the glucose-lowering effect if you're on any pharmacological insulin-sensitizing agents."
— Angelique Nicole R. Villegas, RND, Registered Nutritionist Dietitian · PRC Philippines · License #0023950

Common Questions

Frequently Asked Questions

Both have been studied in PCOS populations — the clinical trials (Fruzzetti 2020, De Cicco 2017, Genazzani 2019, Cirillo 2020) all used standard racemic ALA and showed meaningful effects. R-ALA (pure active enantiomer) has mechanistic advantages for the antioxidant/mitochondrial pathway specifically: it's the form produced by the body, acts as an enzyme cofactor, and has better stability in a sodium R-lipoate form. If your primary focus is the Inflammatory PCOS anti-inflammatory mechanism, R-ALA makes mechanistic sense. If your primary focus is matching the clinical trial doses and keeping cost low, racemic ALA at 400–600mg daily (e.g., NOW 600mg) is the most direct evidence match.

The Inflammatory PCOS phenotype is characterized by elevated inflammatory markers (CRP, HMGB1, oxidative stress biomarkers) contributing to insulin resistance and androgen excess. In some women with PCOS, inflammation is a primary driver of the cycle rather than a downstream effect. ALA addresses this through two pathways: (1) mitochondrial antioxidant activity — ALA and its reduced form DHLA directly scavenge reactive oxygen species and regenerate glutathione; (2) AMPK activation and insulin sensitization via reduction of oxidative stress in insulin-signaling tissues. The Cirillo 2020 study (PMID 32054355) specifically documented HMGB1 reduction with ALA + inositol in PCOS — the most direct published evidence linking ALA to the inflammatory pathway in PCOS.

Yes — and this is the combination most studied in the PCOS clinical literature. De Cicco (2017, PMID 28434274) established that ALA contributes to PCOS improvement via an insulin-independent mechanism, meaning inositol (which works at the insulin second-messenger level) and ALA (which targets upstream antioxidant and AMPK pathways) are mechanistically complementary rather than redundant. Fruzzetti 2020 (PMID 31317814) documented long-term improvements in PCOS with this combination. The standard studied protocol is 2,000mg myo-inositol + 400–600mg racemic ALA daily.

Antioxidant and energy-related effects (reduced fatigue, potentially improved skin condition) may be noticeable within 4–8 weeks. Hormonal endpoint changes — cycle regularity, androgen markers, insulin resistance metrics — require 3–6 months of consistent supplementation. The Fruzzetti 2020 study ran for 6 months. The Genazzani 2019 study assessed insulin responses at shorter intervals. Use objective tracking (cycle length diary, labs at 3 and 6 months) rather than subjective impression to assess whether ALA is contributing meaningfully.

ALA and metformin are often combined in integrative PCOS management, but adding ALA to an existing metformin regimen requires prescriber awareness. Both have insulin-sensitizing and glucose-lowering effects; together they may produce additive lowering of blood glucose. Your prescriber may want to check fasting glucose more frequently in the first 8 weeks of combination use. There are no reported serious adverse interactions between ALA and metformin in the clinical literature at supplement doses, but individual responses vary and monitoring is appropriate.

Scientific References

Citations & Research

This page references peer-reviewed research indexed on PubMed/NCBI. Citations are provided for transparency. Always consult a qualified healthcare professional before making any medical decisions.

[1]Guarano A, Capozzi A, Cristodoro M et al.. “Alpha Lipoic Acid Efficacy in PCOS Treatment: What Is the Truth?.” Nutrients, 2023. PMID 37513627 ↗
[2]Fruzzetti F, Fidecicchi T, Palla G et al.. “Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome..” Gynecological Endocrinology, 2020. PMID 31317814 ↗
[3]De Cicco S, Immediata V, Romualdi D et al.. “Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action..” Gynecological Endocrinology, 2017. PMID 28434274 ↗
[4]Genazzani AD, Prati A, Marchini F et al.. “Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both..” Gynecological Endocrinology, 2019. PMID 31304823 ↗
[5]Cirillo F, Catellani C, Lazzeroni P et al.. “HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)..” Gynecological Endocrinology, 2020. PMID 32054355 ↗

Ready to Try Alpha-Lipoic Acid?

Our top pick for pcos. Third-party tested, highly reviewed.

Shop #1 Pick — Doctor's Best R-Lipoic Acid (BioEnhanced Na-RALA)

Affiliate link — we may earn a commission at no extra cost to you

Continue exploring

Alpha Lipoic Acid supplement guideSupplement overview
pcos support — supplements that may helpGoal overview
our top Berberine pick for pcos supportAlternative supplement
Chromium guidance for pcos supportAlternative supplement
how we rate Alpha Lipoic Acid for antioxidant supportSame supplement, different goal
Inositol reviewed for pcos supportEditor pick
best NAC for pcos supportEditor pick
Alpha Lipoic Acid research for blood sugar supportEditor pick